Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion type Assertion NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_head.
- NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion description "[We studied the association of CCR5*Delta32 with the course and severity of MS in 221 patients from a population-based cohort in Olmsted County, MN, and with patterns of immunopathology in 94 patients with biopsy-derived, pathologically confirmed demyelinating disease participating in the MS Lesion Project.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_provenance.
- NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion evidence source_evidence_literature NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_provenance.
- NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion SIO_000772 16182378 NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_provenance.
- NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion wasDerivedFrom befree-20150227 NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_provenance.
- NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_assertion wasGeneratedBy ECO_0000203 NP569504.RAJgVIVIBQEqJdhsyCTel8FylV9-VCD4nuk1i3XRwibrE130_provenance.